-
1
المؤلفون: Jeanne Heil, Jochen W L Cals, Inge H.M. van Loo, Nicole H. T. M. Dukers-Muijrers, Christian J. P. A. Hoebe, Henriëtte L G Ter Waarbeek
المساهمون: RS: CAPHRI - R4 - Health Inequities and Societal Participation, Med Microbiol, Infect Dis & Infect Prev, Promovendi PHPC, RS: CAPHRI - R5 - Optimising Patient Care, Family Medicine, MUMC+: DA MMI Infectieserologie (9), MUMC+: DA MMI Staf (9), MUMC+: DA MMI AIOS (9)
المصدر: Annals of Family Medicine, 16(1), 21-27. Annals of Family Medicine, Inc
مصطلحات موضوعية: hepatitis C virus, Male, Cost effectiveness, NETHERLANDS, hidden population, Primary Health Care/organization & administration, Chronic/diagnosis, Disease, medicine.disease_cause, Hepatitis C, Chronic/diagnosis, COST-EFFECTIVENESS, 0302 clinical medicine, Prevalence, Mass Screening, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Original Research, GENERAL-POPULATION, GLOBAL EPIDEMIOLOGY, MIGRANTS, RISK, public health, Hepatitis B Surface Antigens/blood, Middle Aged, Hepatitis B, Hepatitis C, Female, 030211 gastroenterology & hepatology, medicine.symptom, Family Practice, INTERVENTIONS, Adult, medicine.medical_specialty, Hepatitis C virus, Netherlands/epidemiology, VIRUS-INFECTION, birth cohort screening, Asymptomatic, 03 medical and health sciences, Hepatitis B, Chronic, Hepatitis C Antibodies/blood, Mass Screening/methods, Internal medicine, medicine, Humans, METAANALYSIS, Aged, Hepatitis B virus, Hepatitis B Surface Antigens, business.industry, Public health, Hepatitis C Antibodies, Hepatitis C, Chronic, medicine.disease, Hepatitis B, Chronic/diagnosis, primary health care, Logistic Models, Multivariate Analysis, hotspots, business, hepatitis B virus
وصف الملف: application/pdf
-
2
المؤلفون: D. S. Chen, W. Hamoudi, B. Mustapha, J. Layden, A. Nersesov, T. Reic, V. Garcia, C. Rios, L. Mateva, O. Njoya, S. A. Al-Busafi, M. K. Abdelmageed, M. Abdulla, D. Adda, O. Akin, A. Al Baqali, N. Al Dweik, K. Al Ejji, I. Al ghazzawi, S. Al Kaabi, K. Al Naamani, J. Al Qamish, M. Al Sadadi, J. Al Salman, M. AlBadri, H. E. Al-Romaihi, W. Ampofo, K. Antonov, C. Anyaike, F. Arome, A. Bane, S. Blach, M. M. Borodo, S. M. Brandon, B. Bright, M. T. Butt, I. Cardenas, H. L. Y. Chan, C. J. Chen, P. J. Chen, R. N. Chien, W. L. Chuang, D. Cuellar, M. Derbala, A. A. Elbardiny, C. Estes, E. Farag, J. Fung, I. Gamkrelidze, J. Genov, Z. Ghandour, M. Ghuloom, B. Gomez, J. Gunter, J. Habeeb, O. Hajelssedig, S. M. Himatt, I. Hrstic, C. C. Hu, C. F. Huang, Y. T. Hui, R. Jahis, D. Jelev, A. K. John, K. S. Kaliaskarova, Y. Kamel, J. H. Kao, J. Khamis, H. Khattabi, I. Khoudri, A. Konysbekova, I. Kotzev, M. S. Lai, W. C. Lao, M. H. Lee, O. Lesi, M. Li, A. Lo, C. K. Loo, B. Lukšić, A. Maaroufi, A. O. Malu, R. Mitova, R. Mohamed, M. Morović, K. Murphy, H. Nde, E. Ngige, R. Njouom, D. Nonković, S. Obekpa, S. Oguche, E. E. Okolo, O. Omede, C. Omuemu, P. Ondoa, O. Opare-Sem, S. Owusu-Ofori, R. O. Phillips, Y. N. Prokopenko, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Redae, T. Rinke de Wit, S. Robbins, L. R. Roberts, S. J. Sanad, M. Sharma, M. Simonova, T. H. Su, K. Sultan, S. S. Tan, K. Tchernev, O. T. Y. Tsang, S. Tsang, C. Tzeuton, S. Ugoeze, B. Uzochukwu, R. Vi, A. Vince, H. U. Wani, V. W. S. Wong, A. Workneh, R. Yacoub, K. I. Yesmembetov, M. Youbi, M. F. Yuen, J. D. Schmelzer
المساهمون: APH - Quality of Care, APH - Personalized Medicine, Global Health, APH - Methodology, ACS - Atherosclerosis & ischemic syndromes
المصدر: Journal of viral hepatitis, 24 Suppl 2, 44-63. Wiley-Blackwell
مصطلحات موضوعية: Antiviral Agents/therapeutic use, Hepatology, Health Policy, Incidence, Disease Management, Chronic/diagnosis, Hepatitis C, Chronic, Global Health, Hepatitis C, Antiviral Agents, Hepatitis C, Chronic/diagnosis, 03 medical and health sciences, 0302 clinical medicine, Infectious Diseases, Viremia/diagnosis, Virology, Prevalence, Humans, 030211 gastroenterology & hepatology, Viremia, 030212 general & internal medicine
-
3
المؤلفون: Jürgen K. Rockstroh, Charles Gore, Hilje Logtenberg-van der Grient, Maria Buti, Jeffrey V. Lazarus, Jens D Lundgren, Stefan Wiktor, Antons Mozalevskis, Stefan Mauss, Dorthe Raben, Eberhard Schatz, Erika Duffell, Stanislas Pol
المصدر: BMC Medicine, Vol 15, Iss 1, Pp 1-5 (2017)
Mauss, S, Pol, S, Buti, M, Duffell, E, Gore, C, Lazarus, J V, der Grient, H L, Lundgren, J, Mozalevskis, A, Raben, D, Schatz, E, Wiktor, S, Rockstroh, J K & European consensus working group on late presentation for Viral Hepatitis Care 2017, ' Late presentation of chronic viral hepatitis for medical care : a consensus definition ', BMC Medicine, vol. 15, 92 . https://doi.org/10.1186/s12916-017-0856-y
BMC Medicineمصطلحات موضوعية: Liver Cirrhosis, Male, medicine.medical_specialty, Consensus, Time Factors, Population, Testing, lcsh:Medicine, Disease, Hepatitis C, Chronic/diagnosis, 03 medical and health sciences, Liver disease, Hepatitis B, Chronic, 0302 clinical medicine, Correspondence, medicine, Humans, 030212 general & internal medicine, Viral hepatitis, Intensive care medicine, education, education.field_of_study, business.industry, lcsh:R, General Medicine, Hepatitis C, Chronic, Jaundice, Hepatitis B, Middle Aged, medicine.disease, Hepatitis B, Chronic/diagnosis, Europe, Late presentation, Hepatocellular carcinoma, Immunology, 030211 gastroenterology & hepatology, Female, medicine.symptom, Transient elastography, business, Liver Cirrhosis/diagnosis
وصف الملف: application/pdf
-
4
المؤلفون: Cécile Brouard, Alexandre Huneau, Daniel Dhumeaux, Adeline Verleene, Yazdan Yazdanpanah, Valérie Canva, Yann Le Strat, Philippe Mathurin, Sabrina Cossais, Sylvie Deuffic-Burban, Josiane Pillonel, Françoise Roudot-Thoraval
المساهمون: Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Lille Inflammation Research International Center - U 995 (LIRIC), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Santé publique France - French National Public Health Agency [Saint-Maurice, France], Service de santé publique [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille], Hôpital Claude Huriez [Lille], CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Services de Maladies Infectieuses et Tropicales [CHU Bichat], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), This work was supported by the French Agence Nationale de Recherche sur le Sida et les Hépatites virales, Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
المصدر: Journal of Hepatology
Journal of Hepatology, Elsevier, 2018, 69 (4), pp.785-792. ⟨10.1016/j.jhep.2018.05.027⟩
Journal of Hepatology, 2018, 69 (4), pp.785-792. ⟨10.1016/j.jhep.2018.05.027⟩مصطلحات موضوعية: Male, Pediatrics, Sustained Virologic Response, Cost effectiveness, Cost-Benefit Analysis, MESH: Sustained Virologic Response, medicine.disease_cause, interferon-free direct-acting antiviral agents, 0302 clinical medicine, MESH: Aged, 80 and over, 030212 general & internal medicine, At-Risk Population, Aged, 80 and over, MESH: Aged, education.field_of_study, cost- effectiveness analysis, MESH: Middle Aged, Incidence (epidemiology), Risk of infection, Health Care Costs, Cost-effectiveness analysis, Middle Aged, Markov Chains, cohort Markov model, MESH: Hepatitis C, Chronic/drug therapy, 3. Good health, MESH: Quality-Adjusted Life Years, MESH: Young Adult, Female, 030211 gastroenterology & hepatology, Quality-Adjusted Life Years, Adult, medicine.medical_specialty, Adolescent, Hepatitis C virus, Population, MESH: Health Care Costs, Context (language use), Young Adult, 03 medical and health sciences, MESH: Markov Chains, medicine, Humans, chronic hepatitis C, education, MESH: Hepatitis C, Chronic/diagnosis, Aged, MESH: Adolescent, MESH: Humans, Hepatology, business.industry, screening, MESH: Quality of Life, MESH: Adult, Hepatitis C, Chronic, MESH: Male, effectiveness analysis, Quality of Life, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Female, MESH: Cost-Benefit Analysis
-
5
المؤلفون: Matthew L. Albert, Yoann Barthe, Armanda Casrouge, Arnaud Fontanet, Stanislas Pol, Sylvie Lagaye, Hélène Fontaine, Vincent Mallet, Philippe Sultanik, Christophe Hézode, Estelle Mottez, Laurent Abel, Etienne Gayat, Céline Dorival, Fabrice Carrat, Jean-Pierre Bronowicki, Ioannis Theodorou
المساهمون: Institut Cochin (IC UM3 (UMR 8104 / U1016)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'hépatologie, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunobiologie des Cellules Dendritiques, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie, systèmes d'information, modélisation, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Departement d'Hépatho-Gastro-Enterologie [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre Hospitalier Universitaire Henri Mondor, Centre d'Immunologie Humaine (CIH), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service de santé publique [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Immunité et Infection, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR113-Institut National de la Santé et de la Recherche Médicale (INSERM), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratory of Human Genetics of Infectious Diseases, Rockefeller University [New York]-Rockefeller Branch, Biomarqueurs CArdioNeuroVASCulaires (BioCANVAS), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of anesthesiology and critical care medicine, Hôpitaux Universitaire Saint-Louis, Lariboisière, Fernand-Widal, Département Infection et Epidémiologie - Department of Infection and Epidemiology, Institut Pasteur [Paris], The CUPIC Cohort study was sponsored and funded by The National Agency for research on Aids and Viral Hepatitis (ANRS), with support by the French Association for the Study of the Liver(AFEF). The authors also wish to acknowledge the Center for Human Immunology for its support of the research project., Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Pasteur [Paris] (IP), CHU Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Centre Hospitalier Universitaire Henri Mondor, Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Saint-Antoine [APHP], Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR113-Université Pierre et Marie Curie - Paris 6 (UPMC), Rockefeller Branch-rockefeller university, Institut Cochin ( UM3 (UMR 8104 / U1016) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP)-Centre Hospitalier Universitaire Henri Mondor, Centre d'Immunologie Humaine ( CIH ), Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Saint-Antoine [APHP], Institut National de la Santé et de la Recherche Médicale ( INSERM ) -IFR113-Université Pierre et Marie Curie - Paris 6 ( UPMC ), Imagine - Institut des maladies génétiques ( IMAGINE - U1163 ), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ), Biomarqueurs CArdioNeuroVASCulaires ( BioCANVAS ), Université Paris Diderot - Paris 7 ( UPD7 ) -Université Paris 13 ( UP13 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Département Infection et Epidémiologie
المصدر: Liver International
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. 〈10.1111/liv.12759〉مصطلحات موضوعية: Male, MESH : Aged, MESH : Prospective Studies, MESH : Viral Load, MESH : Hepatitis C, Chronic/blood, Hepacivirus, MESH : Virus Replication/drug effects, Polyethylene Glycols, MESH: Molecular Targeted Therapy, [ SDV.IMM ] Life Sciences [q-bio]/Immunology, Molecular Targeted Therapy, Prospective Studies, MESH: Ribavirin/therapeutic use, MESH : Proline/analogs & derivatives, MESH: Treatment Outcome, MESH : Hepacivirus/drug effects, MESH: Viral Nonstructural Proteins/metabolism, MESH: Middle Aged, MESH: RNA, Viral/blood, virus diseases, MESH : beta 2-Glycoprotein I/blood, Blood proteins, 3. Good health, beta 2-Glycoprotein I, Area Under Curve, MESH: Hepacivirus/genetics, Drug Therapy, Combination, Oligopeptides, Apolipoprotein H, MESH : Biomarkers/blood, MESH: Hepatitis C, Chronic/drug therapy, Proline, MESH: Hepatitis C, Chronic/blood, virological response, MESH: Proline/analogs & derivatives, MESH : Antiviral Agents/therapeutic use, Antiviral Agents, MESH : Proline/therapeutic use, Boceprevir, MESH : Recombinant Proteins/therapeutic use, Humans, chronic hepatitis C, MESH : Middle Aged, Protease Inhibitors, MESH: Interferon-alpha/therapeutic use, MESH : Predictive Value of Tests, Aged, MESH: Polyethylene Glycols/therapeutic use, MESH : Hepacivirus/genetics, MESH: Humans, Surrogate endpoint, MESH : Humans, MESH: beta 2-Glycoprotein I/blood, MESH: ROC Curve, digestive system diseases, chemistry, MESH: Protease Inhibitors/therapeutic use, Immunology, MESH: Female, Biomarkers, Time Factors, MESH : Viral Nonstructural Proteins/antagonists & inhibitors, MESH : Hepatitis C, Chronic/diagnosis, MESH : Protease Inhibitors/therapeutic use, Viral Nonstructural Proteins, Virus Replication, MESH : Polyethylene Glycols/therapeutic use, HCV protease inhibitor, Telaprevir, MESH: Virus Replication/drug effects, MESH: Proline/therapeutic use, chemistry.chemical_compound, apolipoprotein H, MESH: Hepacivirus/drug effects, MESH : RNA, Viral/blood, MESH : Female, MESH: Hepatitis C, Chronic/diagnosis, MESH : Viral Nonstructural Proteins/metabolism, MESH: Aged, Middle Aged, Viral Load, MESH: Hepacivirus/growth & development, Recombinant Proteins, MESH: Predictive Value of Tests, MESH : Hepacivirus/enzymology, Treatment Outcome, RNA, Viral, biomarker, [SDV.IMM]Life Sciences [q-bio]/Immunology, Biomarker (medicine), Female, France, MESH: Viral Load, MESH : Oligopeptides/therapeutic use, MESH : Time Factors, medicine.drug, MESH : Hepatitis C, Chronic/drug therapy, MESH : Molecular Targeted Therapy, MESH: Biomarkers/blood, MESH: Hepacivirus/enzymology, MESH : Male, MESH : Ribavirin/therapeutic use, MESH : Interferon-alpha/therapeutic use, MESH : Treatment Outcome, Biology, Predictive Value of Tests, MESH: Recombinant Proteins/therapeutic use, Ribavirin, medicine, MESH : France, NS3, MESH: Viral Nonstructural Proteins/antagonists & inhibitors, Hepatology, MESH : Drug Therapy, Combination, MESH: Time Factors, Interferon-alpha, Hepatitis C, Chronic, MESH : Hepacivirus/growth & development, MESH: Male, MESH: Prospective Studies, MESH: France, MESH: Drug Therapy, Combination, ROC Curve, MESH: Antiviral Agents/therapeutic use, MESH: Oligopeptides/therapeutic use, MESH: Area Under Curve, MESH : Area Under Curve, MESH : ROC Curve
-
6
المؤلفون: Deuffic-Burban, Sylvie, Huneau, Alexandre, Verleene, Adeline, Brouard, Cécile, Pillonel, Josiane, Le Strat, Yann, Cossais, Sabrina, Roudot-Thoraval, Françoise, Canva, Valérie, Mathurin, Philippe, Dhumeaux, Daniel, Yazdanpanah, Yazdan
المساهمون: Deuffic-Burban, Sylvie, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Santé publique France - French National Public Health Agency [Saint-Maurice, France], Service de santé publique [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille], Hôpital Claude Huriez [Lille], CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Services de Maladies Infectieuses et Tropicales [CHU Bichat], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), This work was supported by the French Agence Nationale de Recherche sur le Sida et les Hépatites virales
المصدر: Journal of Hepatology
Journal of Hepatology, 2018, 69 (4), pp.785-792. ⟨10.1016/j.jhep.2018.05.027⟩مصطلحات موضوعية: MESH: Adolescent, MESH: Aged, cost- effectiveness analysis, MESH: Middle Aged, MESH: Humans, screening, MESH: Sustained Virologic Response, MESH: Quality of Life, MESH: Health Care Costs, MESH: Adult, cohort Markov model, MESH: Male, MESH: Hepatitis C, Chronic/drug therapy, interferon-free direct-acting antiviral agents, MESH: Quality-Adjusted Life Years, MESH: Aged, 80 and over, effectiveness analysis, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Markov Chains, MESH: Young Adult, chronic hepatitis C, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Hepatitis C, Chronic/diagnosis, MESH: Female, MESH: Cost-Benefit Analysis
وصف الملف: application/pdf
-
7
المؤلفون: Paulien Brunings, Salman Klar, Jane A. Buxton, Gail Butt, Marjan D. Nijkamp
المصدر: Gastroenterology Nursing, 36(4), 249-257. Lippincott Williams and Wilkins Ltd.
Brunings, P, Klar, S, Butt, G, Nijkamp, M D & Buxton, J A 2013, ' "It's a Big Part of Our Lives" : A Qualitative Study Defining Quality of Hepatitis C Care From the Patient's Perspective ', Gastroenterology Nursing, vol. 36, no. 4, pp. 249-257 . https://doi.org/10.1097/SGA.0b013e31829f3f9eمصطلحات موضوعية: Adult, Male, Rural Population, Canada, Urban Population, Attitude of Health Personnel, media_common.quotation_subject, Patient Care Team/organization & administration, Chronic/diagnosis, Stress, Care provision, Severity of Illness Index, Hepatitis C, Chronic/diagnosis, Young Adult, Professional Competence, Nursing, Multidisciplinary approach, Sickness Impact Profile, Surveys and Questionnaires, medicine, Humans, Qualitative Research, media_common, Aged, Quality of Health Care, Advanced and Specialized Nursing, Hepatitis, Patient Care Team, Physician-Patient Relations, British Columbia, business.industry, Gastroenterology, Hepatitis C, Hepatitis C, Chronic, Focus Groups, Middle Aged, medicine.disease, Focus group, Psychological, Female, Clinical Competence, Viral hepatitis, business, Nurse-Patient Relations, Autonomy, Stress, Psychological, Qualitative research
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5222a00a5947f926c8b0ab1ea72b1800
https://doi.org/10.1097/sga.0b013e31829f3f9e -
8
المؤلفون: Jørgen Ingerslev, Alex Lund Laursen, Lars Østergaard, Paul L. Andersen
المصدر: Europe PubMed Central
Laursen, A L, Ingerslev, J, Andersen, P L & Ostergaard, L 1998, ' Viremia in chronic hepatitis C patients evaluated by the Amplicor RT-PCR, a nested RT-PCR, and transaminase levels ', APMIS Supplementum, vol. 106, pp. 334-8 . https://doi.org/10.1111/j.1699-0463.1998.tb01354.xمصطلحات موضوعية: Microbiology (medical), Adult, Male, Adolescent, Polymerase Chain Reaction/methods, Hepacivirus, Hepatitis C virus, Hepacivirus/genetics, Viremia, Chronic liver disease, medicine.disease_cause, Polymerase Chain Reaction, Pathology and Forensic Medicine, Hepatitis C, Chronic/diagnosis, Liver disease, Viremia/diagnosis, medicine, Immunology and Allergy, Humans, Alanine Transaminase/blood, Aged, Aged, 80 and over, biology, virus diseases, Alanine Transaminase, RNA-Directed DNA Polymerase, General Medicine, Hepatitis C, Hepatitis C, Chronic, Middle Aged, medicine.disease, biology.organism_classification, Virology, Alanine transaminase, biology.protein, Female, Viral disease, Reagent Kits, Diagnostic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86534961dc7bb798de90e8dbdb52d012
http://europepmc.org/abstract/med/9531967 -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10مورد إلكتروني
المصدر: Lazarus , J V , Picchio , C , Dillon , J F , Rockstroh , J K , Weis , N & Buti , M 2019 , ' Too many people with viral hepatitis are diagnosed late - with dire consequences ' , Nature Reviews. Gastroenterology & Hepatology , vol. 16 , no. 8 , pp. 451-452 .
مصطلحات الفهرس: Delayed Diagnosis, Hepatitis B, Chronic/diagnosis, Hepatitis C, Chronic/diagnosis, Humans, Point-of-Care Testing, article
URL:
https://curis.ku.dk/portal/da/publications/too-many-people-with-viral-hepatitis-are-diagnosed-late--with-dire-consequences(38002aee-e8ac-49bc-849a-c5e2ac67489a).html https://doi.org/10.1038/s41575-019-0177-z
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.